Biotech News
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
orasure.gcs-web.com2026-05-06 14:57 EST
No Shareholder Action Required at This Time BETHLEHEM, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed that Altai Capital (“Altai”) has